Borderline Ovarian Epithelial Tumor — Trials

Borderline Ovarian Epithelial Tumor — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02101788	Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer	completed	Phase 2 / Phase 3	260	National Cancer Institute (NCI)NIH	2	Aug 4, 2026	clinicaltrials
NCT00551070	Selumetinib Sulfate in Treating Woman With Recurrent Low-Grade Ovarian Cancer or Peritoneum Cancer	completed	Phase 2	52	National Cancer Institute (NCI)NIH	1	Dec 3, 2020	clinicaltrials
NCT00301756	Belinostat in Treating Patients With Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube Cancer or Ovarian Low Malignant Potential Tumors	completed	Phase 2	32	National Cancer Institute (NCI)NIH	1	Aug 20, 2018	clinicaltrials

Data updated 22 days agoSource updated Aug 4, 2026source: clinicaltrials